Highly conserved non-spike SARS-CoV-2 proteins

Highly conserved non-spike SARS-CoV-2 proteins represent a critical class of therapeutic targets that include non-structural proteins (NSPs) and structural proteins such as the nucleocapsid (N), membrane (M), and envelope (E). Unlike the rapidly mutating spike protein, these internal and enzymatic proteins are essential for viral replication, transcription, and assembly, and they exhibit high sequence conservation across different variants of concern. Key targets within this group include the RNA-dependent RNA polymerase (NSP12), which is inhibited by drugs like remdesivir, and the main protease (NSP5/Mpro), which is the target of nirmatrelvir. Additionally, these proteins are being explored as antigens for next-generation universal vaccines designed to elicit robust T-cell responses that are less susceptible to mutational escape. By targeting these conserved elements, therapeutics can achieve broader efficacy against emerging SARS-CoV-2 lineages and potentially other coronaviruses.

Other names

Non-spike SARS-CoV-2 proteinsConserved SARS-CoV-2 antigensSARS-CoV-2 internal proteinsNon-structural proteins (NSPs)Nucleocapsid, Membrane, and Envelope proteins

Inhibition of viral RNA-dependent RNA polymerase (RdRp), inhibition of the main protease (Mpro/3CLpro), and induction of T-cell mediated immunity against conserved structural and non-structural antigens.